Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • FANG vs GSK✓SelectedUSD · GSKFANG vs GSK performance historyLatest closeAs of-0.58%11/20
Stock and ETF performance explorer

FANG vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+23.8%
GSK return
+53.4%
Excess return
-29.6%
Maximum drawdown
-42.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.6%-0.1%-0.5%-0.6%
7D-5.0%-5.3%+0.4%-5.3%
30D-12.0%-3.7%-8.3%-12.1%
3M-16.2%-7.3%-8.9%-16.4%
6M-12.9%-4.2%-8.7%-13.1%
YTD+19.7%+0.9%+18.8%+19.1%
1Y+23.0%+7.3%+15.8%+22.4%
3Y+23.8%+52.7%-29.0%+15.6%
All+23.8%+53.4%-29.6%+15.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling